Alexander C. Clavero | People | McDermott Will & Emery

Overview


Alexander C. Clavero focuses his practice on transactional work, with an emphasis on mergers, acquisitions and divestitures involving private equity sponsors and private companies. He has handled many complex transactions, including leveraged buyouts, private equity acquisitions and divestitures, corporate carve-outs, debt and equity investments, and joint ventures.

Show More

Results


  • Represented Soleo Health, a portfolio company of H.I.G. Capital, in its sale to funds managed by Court Square Capital and WindRose Health Investors. Soleo Health is an industry-leading specialty pharmacy and infusion business that operates 26 pharmacies and more than 30 ambulatory infusion suites across the United States
  • Represented H.I.G. Capital, LLC, a leading global alternative investment firm with $65 billion of capital under management, as its affiliate acquired SkinCure Oncology Intermediate, a provider of advanced, non-surgical treatments for non-melanoma skin cancers
  • Represented H.I.G. Capital, LLC in the sale of its portfolio company, BIOVECTRA Inc. (BIOVECTRA) to Agilent Technologies, Inc. BIOVECTRA is a Canada-based contract development and manufacturing organization for key ingredients used in branded drugs to treat a broad range of complex diseases. H.I.G. acquired BIOVECTRA in 2019

Show More

Recognitions


  • Best Lawyers in America, Mergers and Acquisitions Law, 2025
  • Daily Business Review, On the Rise, 2023
  • IFLR1000, M&A, 2022-2023
  • Law360, Rising Star, 2020

Community


  • Common Threads, board member

Credentials


Education
Fordham University School of Law, JD, cum laude, 2009
Duke University, BA, 2006

Admissions
Florida
New York

Languages
English
Spanish